Literature DB >> 21762660

Cardiac structural and functional alterations in infants and children with biliary atresia, listed for liver transplantation.

Moreshwar S Desai1, Shabier Zainuer, Curtis Kennedy, Debra Kearney, John Goss, Saul J Karpen.   

Abstract

BACKGROUND & AIMS: Cirrhotic liver diseases are associated with abnormalities in cardiac geometry and function in adults (cirrhotic cardiomyopathy) but rarely explored in cirrhotic infants or children. We proposed that features of cirrhotic cardiomyopathy are present in infants with cirrhosis due to biliary atresia (BA) as early as the time of evaluation for liver transplant and will correlate with mortality and postoperative morbidity.
METHODS: Two-dimensional echocardiography (2DE) of infants with BA (n=40; median age, 8 months), listed for transplantation at the Texas Children's Hospital from 2004 to 2010, were reviewed and compared with age- and sex-matched infants without cardiac or liver disease (controls). Length of stay and correlation with 2DE results were assessed.
RESULTS: Compared with controls, children with BA had significant increases in multiple 2DE parameters, notably left ventricle wall thickness (23% increase), left ventricular (LV) mass indexed to body surface area (51% increase), and LV shortening fraction (8% increase). Overall, features of cirrhotic cardiomyopathy were observed in most infants (29/40; 72%); 17 had hyperdynamic contractility, and 24 had altered LV geometry. After liver transplantation (33), infants with abnormal 2DE results had longer stays in the intensive care unit (median, 6 vs 4 days) and the hospital (21 vs 11 days) compared with infants who had normal 2DE reports. On univariate analysis, the length of hospital stay correlated with LV mass index.
CONCLUSIONS: Cardiomyopathy is a prevalent condition in infants with end-stage cirrhotic liver disease due to BA (>70%). This underrecognized condition likely contributes to the prolongation of posttransplant hospitalization.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21762660      PMCID: PMC3740524          DOI: 10.1053/j.gastro.2011.06.082

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  37 in total

1.  CARDIAC HYPERTROPHY IN RATS WITH CARBON TETRACHLORIDE CIRRHOSIS.

Authors:  J H LUNSETH
Journal:  Arch Pathol       Date:  1965-06

2.  Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension.

Authors:  S R Daniels; J M Loggie; P Khoury; T R Kimball
Journal:  Circulation       Date:  1998-05-19       Impact factor: 29.690

3.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

4.  Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease.

Authors:  S R Daniels; T R Kimball; J A Morrison; P Khoury; R A Meyer
Journal:  Am J Cardiol       Date:  1995-10-01       Impact factor: 2.778

5.  Cardiac alterations in cirrhosis: reversibility after liver transplantation.

Authors:  Mireia Torregrosa; Santi Aguadé; Laura Dos; Rosa Segura; Antonio Gónzalez; Artur Evangelista; Joan Castell; Carlos Margarit; Rafael Esteban; Jaume Guardia; Joan Genescà
Journal:  J Hepatol       Date:  2005-01       Impact factor: 25.083

6.  Q-T interval prolongation in liver cirrhosis. Reversibility after orthotopic liver transplantation.

Authors:  G Finucci; F Lunardi; D Sacerdoti; R Volpin; A Bortoluzzi; G Bombonato; P Angeli; A Gatta
Journal:  Jpn Heart J       Date:  1998-05

7.  Analysis of impaired exercise capacity in patients with cirrhosis.

Authors:  S K Epstein; R L Ciubotaru; M D Zilberberg; L M Kaplan; C Jacoby; R Freeman; M M Kaplan
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

8.  Left ventricular hypertrophy in rats with biliary cirrhosis.

Authors:  Javier Inserte; Antonia Perelló; Luis Agulló; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Noelia Escalona; Mariona Graupera; Jaume Bosch; David Garcia-Dorado
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

9.  Spleen length in childhood with US: normal values based on age, sex, and somatometric parameters.

Authors:  Stylianos D Megremis; Ioannis G Vlachonikolis; Amalia M Tsilimigaki
Journal:  Radiology       Date:  2004-02-27       Impact factor: 11.105

10.  Cholic acid and the heart: in vitro studies of the effect on heart rate and myocardial contractility in the rat.

Authors:  P Joubert
Journal:  Clin Exp Pharmacol Physiol       Date:  1978 Jan-Feb       Impact factor: 2.557

View more
  10 in total

1.  Cardiac changes in pediatric liver transplant recipients: are they truly irreversible?

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2016-02-16       Impact factor: 6.047

2.  Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis.

Authors:  Moreshwar S Desai; Zeena Eblimit; Sundararajah Thevananther; Astrid Kosters; David D Moore; Daniel J Penny; Saul J Karpen
Journal:  Liver Int       Date:  2014-01-12       Impact factor: 5.828

3.  Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation.

Authors:  Khemika Khemakanok; Anant Khositseth; Suporn Treepongkaruna; Sumate Teeraratkul; Wichai Pansrimangkorn; Surasak Leelaudomlipi; Uthen Bunmee; Suthus Sriphojanart
Journal:  Hepatol Int       Date:  2015-10-13       Impact factor: 6.047

Review 4.  Cirrhotic cardiomyopathy: a cardiologist's perspective.

Authors:  Natig Gassanov; Evren Caglayan; Nasser Semmo; Gero Massenkeil; Fikret Er
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

5.  Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart.

Authors:  Moreshwar S Desai; Bhoomika Mathur; Zeena Eblimit; Hernan Vasquez; Heinrich Taegtmeyer; Saul J Karpen; Daniel J Penny; David D Moore; Sayeepriyadarshini Anakk
Journal:  Hepatology       Date:  2016-11-29       Impact factor: 17.425

Review 6.  Update on investigations pertaining to the pathogenesis of biliary atresia.

Authors:  Alexandra Kilgore; Cara L Mack
Journal:  Pediatr Surg Int       Date:  2017-10-24       Impact factor: 1.827

7.  Bile acids induce arrhythmias: old metabolite, new tricks.

Authors:  Moreshwar S Desai; Daniel J Penny
Journal:  Heart       Date:  2013-08-22       Impact factor: 5.994

8.  Associations between pediatric choledochal cysts, biliary atresia, and congenital cardiac anomalies.

Authors:  Andrew J Murphy; Jason R Axt; Harold N Lovvorn
Journal:  J Surg Res       Date:  2012-05-01       Impact factor: 2.192

9.  Pulmonary hypertension and cardiac hypertrophy in children recipients of orthotopic living related liver transplantation.

Authors:  Magd A Kotb; Inas Abd El Satar; Ahmed M Badr; Nancy H Anis; Hoda Abd El Rahman Ismail; Alaa F Hamza; Hesham M Abdelkader
Journal:  J Adv Res       Date:  2017-07-27       Impact factor: 10.479

10.  Features of Cirrhotic Cardiomyopathy Early in the Lives of Infants With Biliary Atresia Correlate With Outcomes Following Kasai Portoenterostomy.

Authors:  Jhavene Morrison; Eric Ferguson; Janet Figueroa; Saul J Karpen
Journal:  Hepatol Commun       Date:  2022-01-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.